Application | Comment | Organism |
---|---|---|
medicine | for ABO-incomatible transplantation | Clostridium perfringens |
Cloned (Comment) | Organism |
---|---|
expression in Escherichia coli BL-21 | Clostridium perfringens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
soluble | - |
Clostridium perfringens | - |
- |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Clostridium perfringens | - |
- |
- |
Purification (Comment) | Organism |
---|---|
nickel-nitrilotriacetic acid column | Clostridium perfringens |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
1500 | - |
still acitve after 500-fold dilution of the enzyme | Clostridium perfringens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Galalpha(1-3)[Fucalpha(1-2)]Galbeta(1-4)GlcNAcbeta-R + H2O | analog of blood group B antigen, digested more effciently than the blood group A analog | Clostridium perfringens | Galalpha(1-3)[Fucalpha(1-2)]Gal + GlcNAcbeta-R | - |
? | |
GalNAcalpha(1-3)[Fucalpha(1-2)]Galbeta(1-4)GlcNAcbeta-R + H2O | analog of blood group A antigen | Clostridium perfringens | GalNAcalpha(1-3)[Fucalpha(1-2)]Gal + GlcNAcbeta-R | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ABase | - |
Clostridium perfringens |
endo-beta-galactosidase | - |
Clostridium perfringens |
Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|
4 | - |
stable at 4°C | Clostridium perfringens |